• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Conversion therapy of intermediate and advanced hepatocellular carcinoma using superstable homogeneous iodinated formulation technology.

作者信息

Li Zhenjie, Cheng Hongwei, Mao Jingsong, Liu Gang

机构信息

State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics & Center for Molecular Imaging and Translational Medicine, School of Public Health, Xiamen University, Xiamen, 361102, China.

Department of Radiology, Xiang'an Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, 361102, China.

出版信息

Sci China Life Sci. 2022 Oct;65(10):2114-2117. doi: 10.1007/s11427-022-2142-3. Epub 2022 Aug 26.

DOI:10.1007/s11427-022-2142-3
PMID:36040705
Abstract
摘要

相似文献

1
Conversion therapy of intermediate and advanced hepatocellular carcinoma using superstable homogeneous iodinated formulation technology.使用超稳定均匀碘化制剂技术对中晚期肝细胞癌进行转化治疗。
Sci China Life Sci. 2022 Oct;65(10):2114-2117. doi: 10.1007/s11427-022-2142-3. Epub 2022 Aug 26.
2
Bridging the preoperative gap of precision hepatectomy: Superstable homogeneous iodinated formulation technology.弥合精准肝切除术的术前差距：超稳定均匀碘化制剂技术。
J Interv Med. 2020 Oct 14;4(1):8-10. doi: 10.1016/j.jimed.2020.10.010. eCollection 2021 Feb.
3
A superstable homogeneous lipiodol-ICG formulation for locoregional hepatocellular carcinoma treatment.一种超稳定的均相碘化油-ICG 制剂，用于局部肝癌治疗。
J Control Release. 2020 Jul 10;323:635-643. doi: 10.1016/j.jconrel.2020.04.021. Epub 2020 Apr 14.
4
[Treatment of (unresectable) hepatocellular carcinoma at an intermediate or advanced stage].[中晚期（不可切除）肝细胞癌的治疗]
Rev Med Liege. 2009 Mar;64(3):140-7.
5
Treatment of large and advanced hepatocellular carcinoma.大肝癌及进展期肝癌的治疗
Ann Surg Oncol. 2008 Apr;15(4):979-85. doi: 10.1245/s10434-007-9727-7. Epub 2008 Jan 31.
6
[Advanced hepatocellular carcinoma: importance of clinical trials].[晚期肝细胞癌：临床试验的重要性]
Rev Med Suisse. 2015 May 20;11(475):1149-51.
7
Bridging and downstaging to transplantation in hepatocellular carcinoma.肝细胞癌的桥接治疗及降期至可移植状态
Future Oncol. 2014 Nov;10(15 Suppl):61-3. doi: 10.2217/fon.14.226.
8
Down-staging of hepatocellular carcinoma before liver transplantation: should we change our clinical practice?肝移植前肝细胞癌的降期：我们是否应该改变临床实践？
Ann Surg. 2009 Aug;250(2):348; author reply 348-9. doi: 10.1097/SLA.0b013e3181b1e72a.
9
Transarterial chemoembolization and sorafenib in patients with intermediate-stage hepatocellular carcinoma: time to enter routine clinical practice?经动脉化疗栓塞术与索拉非尼治疗中期肝细胞癌患者：是时候进入常规临床实践了吗？
Future Oncol. 2015;11(17):2371-3. doi: 10.2217/FON.15.173. Epub 2015 Aug 13.
10
Hepatocellular carcinoma in the era of immunotherapy.免疫治疗时代的肝细胞癌
Curr Probl Cancer. 2018 Jan-Feb;42(1):40-48. doi: 10.1016/j.currproblcancer.2017.10.007. Epub 2017 Nov 15.

引用本文的文献

1
Isowalsuranolide targets TrxR1/2 and triggers lysosomal biogenesis and autophagy via the p53-TFEB/TFE3 axis.异沃苏烷内酯靶向硫氧还蛋白还原酶1/2，并通过p53-转录因子EB/转录因子E3轴触发溶酶体生物发生和自噬。
Sci China Life Sci. 2025 Mar 7. doi: 10.1007/s11427-023-2563-6.
2
Dual-drug loaded chondroitin sulfate embolization beads enhance TACE therapy for HCC by integrating embolization, chemotherapy, and anti-angiogenesis.载双药硫酸软骨素栓塞微球通过整合栓塞、化疗和抗血管生成增强肝癌的经动脉化疗栓塞术治疗效果。
Mater Today Bio. 2024 Dec 24;30:101419. doi: 10.1016/j.mtbio.2024.101419. eCollection 2025 Feb.
3
Palindrome-mediated DNA nanotubes with cell-specific aptamers to improve targeted antitumor effects and reduce toxicity on non-small cell lung cancer.

本文引用的文献

1
Optimization of hepatocarcinoma uptake with radiolabeled lipiodol: development of new lipiodol formulations with increased viscosity.放射性碘油标记物对肝癌摄取的优化：新型高粘度碘油制剂的开发。
Cancer Biother Radiopharm. 2012 Mar;27(2):149-55. doi: 10.1089/cbr.2011.1072. Epub 2011 Dec 9.
具有细胞特异性适配体的回文介导DNA纳米管，用于改善靶向抗肿瘤作用并降低对非小细胞肺癌的毒性。
Sci China Life Sci. 2025 Feb;68(2):454-466. doi: 10.1007/s11427-023-2556-4. Epub 2024 Nov 26.
4
TACE plus lenvatinib and tislelizumab for intermediate-stage hepatocellular carcinoma beyond up-to-11 criteria: a multicenter cohort study.TACE 联合仑伐替尼和替雷利珠单抗治疗超 11 项入组标准的中期肝细胞癌：一项多中心队列研究。
Front Immunol. 2024 Jul 26;15:1430571. doi: 10.3389/fimmu.2024.1430571. eCollection 2024.
5
The p38/MAPK pathway as a therapeutic target to prevent therapeutic escape of breast cancer stem cells.p38/MAPK 通路作为一种治疗靶点，以防止乳腺癌干细胞的治疗逃逸。
Sci China Life Sci. 2024 Sep;67(9):1867-1880. doi: 10.1007/s11427-023-2585-5. Epub 2024 Jun 26.
6
Nomograms confirm serum IL-6 and CRP as predictors of immune checkpoint inhibitor efficacy in unresectable hepatocellular carcinoma.列线图证实血清 IL-6 和 CRP 可作为不可切除肝细胞癌免疫检查点抑制剂疗效的预测因子。
Front Immunol. 2024 Jan 18;15:1329634. doi: 10.3389/fimmu.2024.1329634. eCollection 2024.
7
Clinical efficacy and safety evaluation of camrelizumab plus lenvatinib in adjuvant therapy after hepatocellular carcinoma surgery.卡瑞利珠单抗联合仑伐替尼用于肝细胞癌术后辅助治疗的临床疗效及安全性评估
Front Oncol. 2023 Dec 13;13:1174999. doi: 10.3389/fonc.2023.1174999. eCollection 2023.
8
PD-1 combined with lenvatinib and TACE for the transformational treatment of hepatocellular carcinoma combined with portal vein tumor thrombus: a case report and literature review.PD-1联合乐伐替尼及经动脉化疗栓塞术用于肝细胞癌合并门静脉癌栓的转化治疗：一例病例报告及文献综述
Front Oncol. 2023 Oct 5;13:1199143. doi: 10.3389/fonc.2023.1199143. eCollection 2023.
9
The efficacy and safety of different systemic combination therapies on advanced hepatocellular carcinoma: a systematic review and meta-analysis.不同全身联合治疗方案对晚期肝细胞癌的疗效和安全性：一项系统评价和荟萃分析
Front Oncol. 2023 Sep 25;13:1197782. doi: 10.3389/fonc.2023.1197782. eCollection 2023.
10
Integration of Multimodal Computed Tomography Radiomic Features of Primary Tumors and the Spleen to Predict Early Recurrence in Patients with Postoperative Adjuvant Transarterial Chemoembolization.整合原发性肿瘤和脾脏的多模态计算机断层扫描放射组学特征以预测术后辅助经动脉化疗栓塞患者的早期复发
J Hepatocell Carcinoma. 2023 Aug 8;10:1295-1308. doi: 10.2147/JHC.S423129. eCollection 2023.